Serologicals, a provider of biological products and other services to the life science industry, is consolidating two of its research units.

The company (Nasdaq: SERO) said its Chemicon and Upstate groups will now operate under one management structure with the goals of producing more new products in less time and increase per-employee revenue. The sales teams of both groups had already been integrated earlier this year.

Chemicon is based in Temecula CA. Upstate is based in Charlottesville VA.